awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q36911277-AEA96792-9760-4325-B109-E72EFF630CF9
Q36911277-AEA96792-9760-4325-B109-E72EFF630CF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36911277-AEA96792-9760-4325-B109-E72EFF630CF9
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma.
P2860
Q36911277-AEA96792-9760-4325-B109-E72EFF630CF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36911277-AEA96792-9760-4325-B109-E72EFF630CF9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4cc168dc8d56fce35da9039a87e0923f5793c8f4
P2860
Design and rationale for the non-interventional Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma and Of its Treatment with Sorafenib (GIDEON) study.